Our analyses of TIA1 mutations and methylation status in HCC patients, as well as of the expression of predicted or validated TIA1 transcription factors, did not reveal drastic changes in HCC (Supplementary Figure S11). This evidence concerns the gene TIA1 and hepatocellular carcinoma.